Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 Spring;10(1):6-26.
doi: 10.1900/RDS.2013.10.6. Epub 2013 May 10.

Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study

Affiliations
Meta-Analysis

Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study

Giorgina Barbara Piccoli et al. Rev Diabet Stud. 2013 Spring.

Abstract

Background: In the last decade, significant improvements have been achieved in maternal-fetal and diabetic care which make pregnancy possible in an increasing number of type 1 diabetic women with end-organ damage. Optimal counseling is important to make the advancements available to the relevant patients and to ensure the safety of mother and child. A systematic review will help to provide a survey of the available methods and to promote optimal counseling.

Objectives: To review the literature on diabetic nephropathy and pregnancy in type 1 diabetes.

Methods: Medline, Embase, and the Cochrane Library were scanned in November 2012 (MESH, Emtree, and free terms on pregnancy and diabetic nephropathy). Studies were selected that report on pregnancy outcomes in type 1 diabetic patients with diabetic nephropathy in 1980-2012 (i.e. since the detection of microalbuminuria). Case reports with less than 5 cases and reports on kidney grafts were excluded. Paper selection and data extraction were performed in duplicate and matched for consistency. As the relevant reports were highly heterogeneous, we decided to perform a narrative review, with discussions oriented towards the period of publication.

Results: Of the 1058 references considered, 34 fulfilled the selection criteria, and one was added from reference lists. The number of cases considered in the reports, which generally involved single-center studies, ranged from 5 to 311. The following issues were significant: (i) the evidence is scattered over many reports of differing format and involving small series (only 2 included over 100 patients), (ii) definitions are non-homogeneous, (iii) risks for pregnancy-related adverse events are increased (preterm delivery, caesarean section, perinatal death, and stillbirth) and do not substantially change over time, except for stillbirth (from over 10% to about 5%), (iv) the increase in risks with nephropathy progression needs confirmation in large homogeneous series, (v) the newly reported increase in malformations in diabetic nephropathy underlines the need for further studies.

Conclusions: The heterogeneous evidence from studies on diabetic nephropathy in pregnancy emphasizes the need for further perspective studies on this issue.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Study design
In total, 818 articles have been retrieved from database screening. After removal of duplicate and non-relevant articles, 122 have been assessed for eligibility. Of these 122 articles, reviews and further non-relevant articles have been excluded such that finally 35 studies could be included in the present study.

Similar articles

Cited by

References

    1. Reutens AT. Epidemiology of diabetic kidney disease. Med Clin N Am. 2013;97:1–18. - PubMed
    1. Williams ME. Diabetic kidney disease in elderly individuals. Med Clin N Am. 2013;97:75–89. - PubMed
    1. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006;69:2057–2063. - PubMed
    1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–321. - PubMed
    1. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q. et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090–1101. - PubMed